Application Nr Approved Date Route Status External Links
NDA020981 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Hycamtin ® Capsules Are Indicated For The Treatment Of Relapsed Small Cell Lung Cancer (Sclc) In Patients With A Prior Complete Or Partial Response And Who Are At Least 45 Days From The End Of First-Line Chemotherapy. Hycamtin Capsules Is A Topoisomerase Inhibitor Indicated For Treatment Of Patients With Relapsed Small Cell Lung Cancer (Sclc). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Topotecan Hydrochloride TOPOTECAN HYDROCHLORIDE ZINC1611274

Comments